KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Short-Term Debt issuances (2016 - 2025)

HCA Healthcare (HCA) has disclosed Short-Term Debt issuances for 13 consecutive years, with $296.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-Term Debt issuances changed N/A to $296.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 billion, a 217.13% increase, with the full-year FY2025 number at $2.2 billion, up 217.13% from a year prior.
  • Short-Term Debt issuances was $296.0 million for Q4 2025 at HCA Healthcare, up from $138.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $3.7 billion in Q2 2022 to a low of -$3.1 billion in Q2 2023.
  • A 5-year average of $115.9 million and a median of $296.0 million in 2025 define the central range for Short-Term Debt issuances.
  • Biggest YoY gain for Short-Term Debt issuances was 415.28% in 2022; the steepest drop was 3575.0% in 2022.
  • HCA Healthcare's Short-Term Debt issuances stood at $2.3 billion in 2021, then plummeted by 84.65% to $350.0 million in 2022, then increased by 14.29% to $400.0 million in 2023, then crashed by 312.5% to -$850.0 million in 2024, then surged by 134.82% to $296.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCA's Short-Term Debt issuances are $296.0 million (Q4 2025), $138.0 million (Q3 2025), and $1.5 billion (Q2 2025).